Exponent (EXPO) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Feb, 2026Executive summary
Achieved strong Q4 and FY2025 results, driven by diversified growth in proactive and reactive engagements across consumer electronics, utilities, energy, transportation, and life sciences.
Over 50 years of multidisciplinary consulting expertise, serving diverse industries with a focus on technical excellence and objectivity.
Proactive services saw increased demand for user research, especially in AI-enabled consumer electronics and risk management for utilities.
Reactive services grew due to failure analysis and dispute-related work in sectors like energy, construction, and transportation.
Positioned to benefit from trends in safety, health, sustainability, and the proliferation of AI and advanced technologies.
Financial highlights
FY2025 total revenues grew 4.2% to $582.0M; revenues before reimbursements up 3.5% to $536.8M.
Q4 2025 total revenues rose 8% to $147.4M; net revenues up 5% to $129.4M year-over-year, with one less week in the quarter.
FY2025 net income was $106.0M ($2.07/diluted share), down 3% year-over-year.
FY2025 EBITDA was $148.1M (27.6% margin); Q4 2025 EBITDA was $34.7M (26.8% margin).
Cash and equivalents at year-end: $221.9M.
Outlook and guidance
FY2026 revenues before reimbursements expected to grow high single digits year-over-year; EBITDA margin guidance of 27.6%-28.1%.
Technical FTEs expected to increase 4%-5% in 2026; utilization targeted at 72.5%-73%.
Realized rate increase for 2026 expected at 3%-3.5%.
Capital expenditures for 2026 expected at $12M-$14M; tax rate for 2026 expected at 28.5%.
Management confident in long-term growth trajectory, citing strong market drivers and proven operating model.
Latest events from Exponent
- Q2 2024 net income up 14% on flat revenues, with raised guidance and strong sector demand.EXPO
Q2 20242 Feb 2026 - Q3 net income up 6% to $26M, margin guidance raised, and $0.28 dividend declared.EXPO
Q3 202418 Jan 2026 - Q4 and FY24 results exceeded expectations; 2025 growth to be modest amid headcount recovery.EXPO
Q4 202425 Dec 2025 - Flat Q1 revenue, lower net income, and stable 2025 outlook with rising headcount.EXPO
Q1 202523 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and executive pay, all recommended for approval.EXPO
Proxy Filing1 Dec 2025 - Q2 2025 revenues up 1%, lower margins, strong dispute-related growth, positive outlook.EXPO
Q2 202516 Nov 2025 - Q3 2025 delivered double-digit revenue growth, higher net income, and raised margin guidance.EXPO
Q3 20257 Nov 2025